Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. (TRDA) has recorded 17 insider filings from 7 unique insiders, totaling $12.5M in trading activity (net selling). Insiders have sold $4.7M while purchasing $1.6M. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Doshi Dipal. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.